• 31878 Citations
  • 75 h-Index
1982 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Yung Jue Bang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 56 Similar Profiles
Stomach Neoplasms Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Stomach Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1982 2019

Prognostic implications of soluble programmed death-ligand 1 and its dynamics during chemotherapy in unresectable pancreatic cancer

Park, H., Bang, J. H., Nam, A. R., Eun Park, J., Hua Jin, M., Bang, Y. J. & Oh, D-Y., 1 Dec 2019, In : Scientific Reports. 9, 1, 11131.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Pancreatic Neoplasms
Ligands
Drug Therapy
Disease Progression
Tumor Microenvironment

GC1118, a novel anti-EGFR antibody, has potent KRAS mutation-independent antitumor activity compared with cetuximab in gastric cancer

Park, J. E., Jin, M. H., Hur, M., Nam, A. R., Bang, J. H., Won, J., Oh, D-Y. & Bang, Y. J., 5 Sep 2019, In : Gastric Cancer. 22, 5, p. 932-940 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Stomach Neoplasms
Anti-Idiotypic Antibodies
Mutation
Cytotoxins
Ligands

Enhanced antitumor effect of binimetinib in combination with capecitabine for biliary tract cancer patients with mutations in the RAS/RAF/MEK/ERK pathway: phase Ib study

Kim, J. W., Lee, K. H., Kim, J. W., Suh, K. J., Nam, A. R., Bang, J. H., Bang, Y. J. & Oh, D-Y., 13 Aug 2019, In : British Journal of Cancer. 121, 4, p. 332-339 8 p.

Research output: Contribution to journalArticleResearchpeer-review

Biliary Tract Neoplasms
MAP Kinase Signaling System
Mutation
gemcitabine
Disease-Free Survival

Jab1 silencing inhibits proliferation and sensitizes to cisplatin in biliary tract cancer

Nam, A. R., Kim, J. W., Park, J. E., Bang, J. H., Jin, M. H., Oh, D-Y. & Bang, Y. J., 1 Jul 2019, In : Cancer Research and Treatment. 51, 3, p. 886-900 15 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Biliary Tract Neoplasms
Cisplatin
Small Interfering RNA
G1 Phase Cell Cycle Checkpoints
DNA Damage

Therapeutic targeting of the DNA damage response using an ATR inhibitor in biliary tract cancer

Nam, A. R., Jin, M. H., Park, J. E., Bang, J. H., Oh, D-Y. & Bang, Y. J., 1 Jul 2019, In : Cancer Research and Treatment. 51, 3, p. 1167-1179 13 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Biliary Tract Neoplasms
Ataxia Telangiectasia
DNA Damage
Cytotoxins
Comet Assay